Start | Browse by Day | Author Index | Keyword Index

Quality of Life, Sleep Disorders and Serum Orexin in Persons with Hemodialysis Treatment

Monday, 27 July 2015: 10:00 AM

Christian F. Rodríguez-Pérez, RN
Department of Nursing and Obstetrics. Health Sciences Division., Universidad de Guanajuato Leon Campus, León Guanajuato, Mexico
Luxana Reynaga-Ornelas, PhD, MSN, RN
Departamento de Enfermería y Obstetricia Sede León. Cuerpo Académico Salud Integral, Universidad de Guanajuato Campus León. División de Ciencias de la Salud, León, Gto, Mexico
Karla S. Vera-Delgado, MSc, RN
Departamento de Enfermería y Obstetricia, Sede Guanajuato, Universidad de Guanajuato, Guanajuato, Mexico
Octavio A. Jimenez-Garza, MS, RN
Nursing and Obstetrics, Universidad de Guanajuato Campus Leon, Leon GTO, Mexico
Carol M. Baldwin, PhD, RN, AHN-BC, FAAN
College of Health Solutions and College of Nursing & Health Innovation; Southwest Borderlands Scholar; Director, Center for World Health Promotion & Disease Prevention, Arizona State University, Phoenix, AZ

Purpose:

The evaluation of the patients’ health-related quality of life (HRQOL) represents the impact of the disease and its subsequent treatment on the perception of the their own wellness. The purpose of this study was ti examin the relationship between HRQOL, sleep disorders and serum levels of orexin.

Methods:

This analytical study included 39 adults in renal replacement therapy (hemodialysis ) who signed the informed consent for participation. KDQOLSF -36 questionnaire and sleep habits questionnaire (SHHS) were used. Blood samples were taken for determination of orexin levels and analyzed by enzyme immunoassay technique (EIA) . Data was captured and analyzed with the SPSS statistics package version18. Results are reported as means, standard deviations and percentages . The Pearson correlation test was used to analyze associations between the study variables and HRQOL scores. 

Results: 

HRQOL scores were lower in the dimensions of physical role and emotional role of SF-36 KDQOL as resulting in 28.8 and 29 respectively on a scale from 0 to 100 where the higher the score, the better CV perceived. In the subscales that comprise the physical component of HRQOL (PCS) the score was 40.3 and 42.9 in the mental component (MCS). HRQOL related to kidney disease and its treatment was more affected in the burden of disease and employment dimenisons (scores of 38.5 and 39.7 respectively). Sleep disorders more frequently reported were: light sleep (36%), restless sleep (28%), snoring (56%), sense of urgency to move the legs (53%), daytime sleepiness (23%) and insomnia (30%). Negative correlations were found between the physical component  score of HRQOL and minutes taken to sleep (r=-.423; p =,007), dificultty to  stay asleep (r=-.482; p=,002), waking up at night and having difficulty to go back to sleep ( r=-.437; p=0.005), feeling sleepy during the day (r=.525; p=,001), stoping breathing during sleep (r=-.578; p=.000). Negative correlations were also found between the mental component score of HRQOL and minutes taken to sleep (r=-.410; p=.008) and between quality of sleep (movement) and serum orexin (r=-. 363; p=,023). Positive correlations were found between the physical component of HRQOL and the quality of sleep (0-10)(r=.563; p=.000), quality of sleep (profundidad)(r=.322, p=.046), the mental component of HRQOL and quality of sleep (0-10) (r=.497; p=.001) and minutes to fall asleep with serum orexins (r =.407 p=,010). 

Conclusion:

Sleep disorders are related with lower scores of perceived HRQOL. Serum orexin levels are related with reported sleep disorders in Mexicans with hemodialysis.  No relationship was found between HRQOL and serum orexins. The role of orexins in sleep disorders reported by persons with hemodialysis treatment needs to be investigated in further studies.

See more of: Issues that Affect Patients' Quality of Life
See more of: Research Sessions: Oral Paper & Posters